The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Evaluation of the reinforcing properties and phencyclidine-like discriminative stimulus effects of dextromethorphan and dextrorphan in rats and rhesus monkeys
Abstract
Rationale Dextromethorphan (DXM) and its metabolite, dextrorphan (DXO) have neuroprotective and anticonvulsant properties through their activity as N-methyl-D-aspartate (NMDA) receptor channel blockers. Based on this receptor activity, coupled with reports of DXM abuse, both were evaluated for abuse potential and phencyclidine (PCP)-like behavioral effects in two animal models. Objectives and methods The discriminative stimulus properties of DXO and DXM were tested in rats (3-56 mg/kg DXM, i.p. and 2.2-40.9 mg/kg DXO, i.p.) and rhesus monkeys (0.3-10 mg/kg DXM, i.m. and 0.25-8.0 mg/kg DXO, i. m.) trained to discriminate PCP from saline using a standard two-lever drug-discrimination paradigm under a fixed-ratio (FR) schedule of food reinforcement. In a second set of experiments, i.v. self-administration of DXO (10-100 microg/kg/infusion) and DXM (10-1000 microg/kg/infusion) were tested under a FR schedule of reinforcement in monkeys trained to lever press for infusions of PCP during daily 1-h sessions. Results In rats, both DXM and DXO produced a dose-dependent substitution for PCP. When tested in monkeys, DXM yielded partial (1 monkey) and full (2 monkeys) substitution for PCP, while DXO substituted fully for PCP in all four subjects tested. In the self-administration study, in five of the six subjects, at least one dose of DXM served as a positive reinforcer, maintaining infusion rates above those for saline. For DXO, at least one dose maintained infusion numbers well above…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The behavioral pharmacology of NMDA receptor antagonists
Willetts, J., Balster, R. L., & Leander, J. D. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90150-7 · Cited by 330
Self-citationParsons, C. G., Quack, G., Bresink, I., Baran, L., Przegalinski, E., Kostowski, W., Krzascik, P., Hartmann, S., & Danysz, W. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00092-k · Cited by 311
Parsons, C. G., Gruner, R., Rozental, J., Millar, J., & Lodge, D. (1993) · Neuropharmacology · doi:10.1016/0028-3908(93)90029-3 · Cited by 279
Mao, J., Price, D. D., Hayes, R. L., Lu, J., Mayer, D. J., & Frenk, H. (1993) · Brain Research · doi:10.1016/0006-8993(93)91368-3 · Cited by 238
Dextromethorphan An Overview of Safety Issues
Bem, J. L., & Peck, R. (1992) · Drug Safety · doi:10.2165/00002018-199207030-00004 · Cited by 223
Drug abuse potential evaluation in animals
BALSTER, R. L. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01747.x · Cited by 179
Self-citationBrady, K. T., Balster, R. L., & May, E. L. (1982) · Science · doi:10.1126/science.6274022 · Cited by 165
Self-citationPhencyclidine-like discriminative effects of opioids in the rat.
Holtzman, S. G. (1980) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32225-1 · Cited by 158
Johanson, C. E., & Balster, R. L. (1978) · PubMed · Cited by 152
Self-citationChurch, J., Lodge, D., & Berry, S. C. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90755-1 · Cited by 150
Cited by
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
Halberstadt, A. L. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.016 · Cited by 312
“It is also surprising that none of the subjects classified dextromethorphan as a dissociative anesthetic, since dextromethorphan is abused for its dissociative-like effects (Boyer, 2004) and produces phencyclidine- and ketamine-like discriminative stimulus effects in rats (Nicholson et al., 1999; Narita et al., 2001).”
BackgroundA REVIEW OF KETAMINE ABUSE AND DIVERSION: Review: Ketamine
Sassano-Higgins, S., Baron, D., Juarez, G., Esmaili, N., & Gold, M. (2016) · Depression and Anxiety · doi:10.1002/da.22536 · Cited by 204
The predictive validity of the rat self-administration model for abuse liability
O’Connor, E. C., Chapman, K., Butler, P., & Mead, A. N. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.012 · Cited by 203
Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block
Dravid, S. M., Erreger, K., Yuan, H., Nicholson, K., Le, P., Lyuboslavsky, P., Almonte, A., Murray, E., Mosley, C., Barber, J., et al. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2006.124958 · Cited by 184
Self-citationHigh doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens
Reissig, C. J., Carter, L. P., Johnson, M. W., Mintzer, M. Z., Klinedinst, M. A., & Griffiths, R. R. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2680-6 · Cited by 92
Dextromethorphan psychosis, dependence and physical withdrawal
Miller, S. C. (2005) · Addiction Biology · doi:10.1080/13556210500352410 · Cited by 83
渉, 日. (2004) · Pediatric Emergency Care · doi:10.1097/01.pec.0000148039.14588.d0 · Cited by 75
Antitussives and substance abuse
Boyer, E. W., & Burns, J. M. (2013) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s36761 · Cited by 67
Dextromethorphan-bupropion (Auvelity) for the Treatment of Major Depressive Disorder
McCarthy, B., Bunn, H., Santalucia, M., Wilmouth, C., Muzyk, A., & Smith, C. M. (2023) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.23.1081 · Cited by 63
Glick, S. D., Maisonneuve, I. M., Dickinson, H. A., & Kitchen, B. A. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01066-4 · Cited by 63
Pharmacokinetics and pharmacodynamics of dextromethorphan: clinical and forensic aspects
Silva, A. R., & Dinis‐Oliveira, R. J. (2020) · Drug Metabolism Reviews · doi:10.1080/03602532.2020.1758712 · Cited by 61
Horton, D. B., Potter, D. M., & Mead, A. N. (2013) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283644d2e · Cited by 60
Bisaga, A. M., Popik, P., Bespalov, A., & Danysz, W. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.10.2233 · Cited by 54
Heal, D. J., Gosden, J., & Smith, S. L. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.049 · Cited by 52
Studies with psychedelic drugs in human volunteers
Sellers, E. M., Romach, M. K., & Leiderman, D. B. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.029 · Cited by 42
Hendrickson, H. P., Gurley, B. J., & Wessinger, W. D. (2003) · Journal of Chromatography B · doi:10.1016/s1570-0232(02)01042-5 · Cited by 33
Club drugs: los viejos fármacos son las nuevas drogas de la fiesta
Abanades, S., Peiró, A. M., & Farré, M. (2004) · Medicina Clínica · doi:10.1016/s0025-7753(04)74499-1 · Cited by 29
Marier, J., Deschênes, J.-L., Hage, A., Seliniotakis, E., Gritsas, A., Flarakos, T., Beaudry, F., & Vachon, P. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.04.025 · Cited by 28
Nicholson, K. L., Mansbach, R. S., Menniti, F. S., & Balster, R. L. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282f14ed6 · Cited by 27
Self-citationPechnick, R. N., & Poland, R. E. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.060038 · Cited by 24
Babu, K. M., Boyer, E. W., Hernon, C., & Brush, D. E. (2005) · Clinical Pediatric Emergency Medicine · doi:10.1016/j.cpem.2005.04.002 · Cited by 22
Dextromethorphan alters methamphetamine self-administration in the rat
Jun, J. H., & Schindler, C. W. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00317-8 · Cited by 20
Schatzberg, A. F. (2022) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20220434 · Cited by 20
Munzar, P., Li, H., Nicholson, K. L., Wiley, J. L., & Balster, R. L. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0989-7 · Cited by 19
Self-citationMori, T., Yoshizawa, K., Nomura, M., Isotani, K., Torigoe, K., Tsukiyama, Y., Narita, M., & Suzuki, T. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00306.x · Cited by 17
Comparative effects of dextromethorphan and dextrorphan on nicotine discrimination in rats
Wright, M. J., Vann, R. E., Gamage, T. F., Damaj, M. I., & Wiley, J. L. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.09.020 · Cited by 17
Henningfield, J. E., Gauvin, D. V., Bifari, F., Fant, R. V., Shram, M. J., Buchhalter, A. R., Ashworth, J., Lanier, R. K., Pappagallo, M., Inturrisi, C. E., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-15055-3 · Cited by 15
Nicholson, K. L., & Balster, R. L. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1527-6 · Cited by 15
Self-citationCORICIDIN® HBP COUGH AND COLD ADDICTION
Miller, S. C. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000159160.91833.b8 · Cited by 15
Schindler, C. W., Jun, J. H., & Thorndike, E. B. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1650-4 · Cited by 14
The selective glycine antagonist gavestinel lacks phencyclidine-like behavioral effects
Beardsley, P. M., Ratti, E., Balster, R. L., Willetts, J., & Trist, D. G. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200211000-00007 · Cited by 14
Self-citationUnger, K., & Watterson, J. H. (2016) · Journal of Analytical Toxicology · doi:10.1093/jat/bkw083 · Cited by 11
Influence of concomitant quinidine administration on dextromethorphan disposition in rats
Marier, J., Pope, L. E., Yakatan, G. J., Berg, J. E., Stiles, M. R., & Vachon, P. (2004) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.2004.00559.x · Cited by 10
Swalve, N. L., Pittenger, S. T., Bevins, R. A., & Li, M. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3923-0 · Cited by 8
Treatment of Dextromethorphan Dependence with Naltrexone
Miller, S. C. (2005) · Addictive Disorders & Their Treatment · doi:10.1097/01.adt.0000186359.43340.76 · Cited by 7
The Abuse Liability of Dextromethorphan Among Adolescents: A Review
Bobo, W. V., Miller, S. C., & Martin, B. D. (2005) · Journal of Child & Adolescent Substance Abuse · doi:10.1300/j029v14n04_04 · Cited by 7
The “new wave” of antidepressants: are these agents paradigm-shifters in treating major depression?
Petrescu, B. M., Marinescu, I. P., Marinescu, D., Vasiliu, O., Mangalagiu, A. G., & Cândea, C. A. (2023) · Psihiatru ro · doi:10.26416/psih.75.4.2023.8926 · Cited by 4
Bespalov, A., Beardsley, P. M., & Todtenkopf, M. S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-420172-9.00008-4 · Cited by 3
Gundeti, M., Murthy, A. N., Jamdade, S., & Ahmed, T. (2024) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2389 · Cited by 3
Dissociative Agents: Phencyclidine, Ketamine and Dextromethorphan
Liang, I. E., & Boyer, E. W. (2007) · Elsevier eBooks · doi:10.1016/b978-0-7216-0693-4.50048-7 · Cited by 3
Effects of dextromethorphan on rats' acquisition of responding with delayed reinforcement
MORGAN, T., Porritt, M., & Poling, A. D. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.10.019 · Cited by 2
Wallace, D. R., & Crosswy, K. K. (2017) · Toxicology and Forensic Medicine - Open Journal · doi:10.17140/tfmoj-2-120 · Cited by 2
Immunomodulatory Changes Induced By High Doses Of Dextromethorphan In Male Rats
Rabei, H. M. (2013) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2013.15975 · Cited by 1
Nicholson, K. L., & Balster, R. L. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200211000-00006 · Cited by 1
Self-citationMatsumoto, R. R., & Pouw, B. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-306-4_16
Metabolic interactions between over-the-counter and illicit drugs at cytochrome P450
Crosswy, K. K. (2007)
The Effects of Dextromethorphan on Response Acquisition with Delayed Reinforcement
Morgan, T. B. (2005) · ScholarWorks - WMU (Western Michigan University)
Application of Pharmacogenetics and Pharmacogenomics in Pediatrics: What Makes Children Different?
Lowry, J. A., & Leeder, J. S. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139051194.025
Preston, K. L., Schmittner, J. P., Epstein, D. H., & WALSH, S. L. (2007) · CRC Press eBooks · doi:10.1201/9781420054606.ch8
Mann-Jones, J. M. (2003) · Research Exchange (Washington State University)
Heishman, S. J. (2006) · CRC Press eBooks · doi:10.1201/9781420003468.ch4
Dextromethorphan Beyond the Cough: Exploring Its Psychedelic Potential: A Systematic Review
Hackett, E. P., -, A. C., Hasman, L., Thakur, R., Scott, M. J., & Dworkin, R. H. (2026) · CNS Drugs · doi:10.1007/s40263-026-01305-9
Katsuki, H., Kamijo, Y., Takai, M., Kohara, S., Fukushima, H., Mizuno, Y., Ochiai, H., Otani, N., Taguchi, D., Shimane, T., et al. (2026) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.70406
Metadata
- Authors
- Nicholson, K. L., Hayes, B. A., & Balster, R. L.
- Affiliations
- Virginia Commonwealth University (US)
- United States Food and Drug Administration (US)
- Venue
- Psychopharmacology
- Published
- 1999-09-03
- Volume
- 146
- Issue
- 1
- Pages
- 49-59
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2010580044
- Cited by
- 52
- References
- 60
- Citations by year
- 2026: 2 · 2024: 1 · 2023: 2 · 2022: 2 · 2020: 1 · 2018: 1 · 2017: 2 · 2016: 2 · 2015: 2 · 2014: 1 · 2013: 2 · 2012: 2
- FWCI
- 0.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (DA 07027, DA-01442, R01DA001442, T32DA007027)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- dextromethorphan, dextrorphan, abuse liability, discriminative stimulus, self-administration, NMDA receptor antagonism, drug substitution, drug abuse, rhesus monkeys, rats
- MeSH terms
- Animals, Antitussive Agents, Dextromethorphan, Discrimination Learning, Dose-Response Relationship, Drug, Macaca mulatta, Male, Phencyclidine, Reinforcement, Psychology, Self Administration, Receptors, N-Methyl-D-Aspartate, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.